A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
A test model of the Perseverance rover, designed to explore the surface of Mars, sits in a garage at NASA’s Jet Propulsion ...
Tessellations aren’t just eye-catching patterns—they can be used to crack complex mathematical problems. By repeatedly ...
Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health ...
Grand Cayman, Cayman Islands, January 6th, 2026, ChainwireThe Buck Foundation is launching the world’s first Bitcoin ...
Our updated two-round NBA Mock Draft projections include an Indiana Pacers heist, a dangerous Oklahoma City Thunder addition, ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea (narsoplimab-wuug) for hematopoietic stem cell transplant-associated thrombotic ...
It took Kentucky basketball coach Mark Pope until early January to set his rotation. Now, for better or worse, these Cats ...
Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback